<DOC>
	<DOC>NCT00090272</DOC>
	<brief_summary>The objective of this study is to evaluate the safety and efficacy of a one time dose of an intravenous marketed drug being evaluated for a new indication as compared to a marketed drug already approved for the prevention of surgical site infection following colorectal surgery.</brief_summary>
	<brief_title>A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)</brief_title>
	<detailed_description>The duration of treatment is 1 day.</detailed_description>
	<mesh_term>Surgical Wound Infection</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<mesh_term>Cefotetan</mesh_term>
	<criteria>Male or female patients 18 years of age scheduled to undergo elective colon or colorectal surgery by laparotomy must meet the following criteria: Surgery must be scheduled in advance. There must be adequate time to complete preoperative bowel preparation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>